Trbojević-Akmačić, Irena http://orcid.org/0000-0003-0106-0155
Vučković, Frano http://orcid.org/0000-0002-4845-0882
Pribić, Tea
Vilaj, Marija
Černigoj, Urh
Vidič, Jana
Šimunović, Jelena
Kępka, Agnieszka
Kolčić, Ivana
Klarić, Lucija http://orcid.org/0000-0003-3105-8929
Novokmet, Mislav
Pučić-Baković, Maja http://orcid.org/0000-0003-0866-623X
Rapp, Erdmann http://orcid.org/0000-0001-6618-2626
Štrancar, Aleš
Polašek, Ozren
Wilson, James F. http://orcid.org/0000-0001-5751-9178
Lauc, Gordan http://orcid.org/0000-0003-1840-9560
Article History
Received: 11 November 2022
Accepted: 9 March 2023
First Online: 23 March 2023
Competing interests
: The authors declare the following competing interests: G.L. is the founder and owner of Genos Ltd, a private research organization that specializes in high-throughput glycomic analysis and has several patents in this field. I.T.-A., F.V., T.P., M.V., J.Š., M.N., and M.P.B. are employees of Genos Ltd. A.Š. is the founder and managing director of BIA Separations Ltd, a Sartorius company, focused on the development of monolith technology and production of CIM® (convective interaction media) chromatographic columns for the production, purification, and analysis of large biomolecules. U.Č. and J.V. are employees of BIA Separations Ltd. E.R. is co-affiliated with glyXera GmbH. glyXera provides high-performance glycoanalytical products and services and holds several patents for xCGE-LIF and MALDI-MS-based glycoanalysis. The other authors declare no competing interests.